Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials

Phase I Dose-escalation Study of Two Doses GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials